totally correct in what you say, the FDA have shown great confidence in this medical procedure. With burns they gave approval for application on adults only and delayed on juveniles then not long after issued full approval for all burns.Know surgeons who were looking with interested and were caught out, unaware they had accelerated the the juvenile approval for burns they rushed off and began buying shares. For wounds when they got approval for the recell wounds they applied for the FDA added all wounds much to the surprise of recell. Top this of with two of the biggest fund managers on the planet taking up sizeable chunks of share holdings tells you these too have a great confidence.
Ann: AVITA Medical Q4 2023 Investor Presentation, page-60
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.14 |
Change
0.140(4.67%) |
Mkt cap ! $213.8M | |||
| Open | High | Low | Value | Volume |
| $3.08 | $3.17 | $3.08 | $922.4K | 295.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1432 | $3.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.14 | 107 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |